AMIXAN 100 contains Amikacin 100 mg Injection, an aminoglycoside antibiotic intended for serious susceptible bacterial infections requiring parenteral therapy. A specialized PCD Pharma Injectable Antibiotic portfolio product.
Serious infections caused by susceptible bacteria.
Yes, particularly kidney function and, where appropriate, drug levels.
Use only under medical supervision. Monitor renal function and hearing where clinically indicated. Inform the physician about kidney disease and other medicines with nephrotoxic or ototoxic potential.
Injection-site reactions, nausea, dizziness and fever may occur. Important risks include kidney toxicity and hearing/balance impairment.
AMIXAN 100: Amikacin binds to the bacterial 30S ribosomal subunit, inhibiting protein synthesis and producing bactericidal activity against susceptible organisms.
